S. Kioufis

发表

Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.

P. Stone, A. Papavassiliou, D. Tousoulis, 2015, Atherosclerosis.

Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease.

C. Stefanadis, D. Tousoulis, G. Siasos, 2013, International journal of cardiology.

Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance

C. Stefanadis, D. Tousoulis, G. Siasos, 2017, Cardiology.

The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel.

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2013, International journal of cardiology.

Impact of C34T P2Y12 ADP receptor polymorphism and smoking status on cardiovascular outcome in coronary artery disease patients receiving clopidogrel.

D. Tousoulis, G. Siasos, E. Oikonomou, 2016, International journal of cardiology.

Abstract 15708: Effects of CYP2C19 Genotype on Arterial Wall Properties in Patients with Coronary Artery Disease Receiving Clopidogrel

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2012 .

Abstract 9993: Friedreich Ataxia is Associated with Endothelial Dysfunction and Increased Arterial Stiffness

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2011 .

Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2013, International journal of cardiology.

High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel.

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2014, International journal of cardiology.

Effects of Ω-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: a cross over study.

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2013, International journal of cardiology.

Impact of C34T P2Y12 genotype on endothelial function and arterial stiffness in patients after percutaneous coronary intervention receiving clopidogrel.

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2014, International journal of cardiology.

The impact of AMPD1 gene polymorphism on vascular function and inflammation in patients with coronary artery disease.

C. Stefanadis, D. Tousoulis, G. Siasos, 2014, International journal of cardiology.

VASCULAR FUNCTION AND OCULAR INVOLVEMENT IN SARCOIDOSIS

C. Stefanadis, D. Tousoulis, G. Siasos, 2014 .

Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2012, Current topics in medicinal chemistry.

THE IMPACT OF PHYSICAL ACTIVITY ON TOTAL ANTIOXIDANT CAPACITY AND ENDOTHELIAL FUNCTION: IKARIA STUDY

D. Panagiotakos, A. Papavassiliou, C. Stefanadis, 2013 .

HIGH PLATELET REACTIVITY IS ASSOCIATED WITH VASCULAR FUNCTION IN PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION RECEIVING CLOPIDOGREL

C. Stefanadis, D. Tousoulis, G. Siasos, 2015 .

High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel.

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2014, International journal of cardiology.

Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2013, International journal of cardiology.

The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel.

A. Papavassiliou, C. Stefanadis, D. Tousoulis, 2013, International journal of cardiology.

Vitamin D3, D2 and arterial wall properties in coronary artery disease.

C. Stefanadis, D. Tousoulis, G. Siasos, 2014, Current pharmaceutical design.